PATENT CLAIM ANALYSIS

Application Number: 15939828
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
The invention relates to pharmaceutical compositions containing both (+)-α-dihydrotetrabenazine and (−)-α-dihydrotetrabenazine and their therapeutic uses, for example in the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 5):
A method of treating a movement disorder in a subject (e.g. a human subject) in need thereof, the method comprising administering to the subject:\n (a) a combination of (+)-\u03b1-dihydrotetrabenazine and (\u2212)-\u03b1-dihydrotetrabenazine, or pharmaceutically acceptable salts thereof; or (b) a pharmaceutical unit dosage form comprising a combination of (+)-\u03b1-dihydrotetrabenazine and (\u2212)-\u03b1-dihydrotetrabenazine, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15939837', '15939826', '12555695', '15116786', '15044655']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7912844294809189
- 35 USC 102 Novelty (BERT): 0.6260238362432473
- Combined Prediction Score: 0.7747583701571518
- Mean Citation Score: 426.957636
- Max Citation Score: 652.2701
- Similarity Product: 516.5462471033692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test